{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:32:05Z","timestamp":1764714725795},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T00:00:00Z","timestamp":1432944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s10096-015-2414-x","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T12:35:20Z","timestamp":1432902920000},"page":"1797-1802","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy"],"prefix":"10.1007","volume":"34","author":[{"given":"G.","family":"Gherardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Petrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Di Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pimentel de Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bernaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Repetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bellesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,30]]},"reference":[{"key":"2414_CR1","first-page":"2362","volume-title":"Principles and practice of infectious diseases","author":"AL Bisno","year":"2005","unstructured":"Bisno AL, Stevens DL (2005) Streptococcus pyogenes. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Elsevier, Philadelphia, pp 2362\u20132379","edition":"6"},{"key":"2414_CR2","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/AAC.48.9.3559-3562.2004","volume":"48","author":"E Bingen","year":"2004","unstructured":"Bingen E, Bidet P, Mihaila-Amrouche L, Doit C, Forcet S, Brahimi N et al (2004) Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother 48:3559\u20133562. doi: 10.1128\/AAC.48.9.3559-3562.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1469-0691.2003.00598.x","volume":"9","author":"B Bozdogan","year":"2003","unstructured":"Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A, Drukalska L et al (2003) Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe. Clin Microbiol Infect 9:741\u2013745. doi: 10.1046\/j.1469-0691.2003.00598.x","journal-title":"Clin Microbiol Infect"},{"key":"2414_CR4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.40.8.1817","volume":"40","author":"J Sutcliffe","year":"1996","unstructured":"Sutcliffe J, Tait-Kamradt A, Wondrack L (1996) Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40:1817\u20131824","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/MB:28:1:47","volume":"28","author":"MC Roberts","year":"2004","unstructured":"Roberts MC (2004) Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol Biotechnol 28:47\u201362. doi: 10.1385\/MB:28:1:47","journal-title":"Mol Biotechnol"},{"key":"2414_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(00)05253-3","volume":"358","author":"B Facinelli","year":"2001","unstructured":"Facinelli B, Spinaci C, Magi G, Giovanetti E, Varaldo PE (2001) Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30\u201333. doi: 10.1016\/S0140-6736(00)05253-3","journal-title":"Lancet"},{"key":"2414_CR7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/383309","volume":"38","author":"M Bergman","year":"2004","unstructured":"Bergman M, Huikko S, Pihlajam\u00e4ki M, Laippala P, Palva E, Huovinen P et al (2004) Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997\u20132001. Clin Infect Dis 38:1251\u20131256. doi: 10.1086\/383309","journal-title":"Clin Infect Dis"},{"key":"2414_CR8","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1128\/AAC.01133-12","volume":"56","author":"C Silva-Costa","year":"2012","unstructured":"Silva-Costa C, Fri\u00e3es A, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections (2012) Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption. Antimicrob Agents Chemother 56:5661\u20135666. doi: 10.1128\/AAC.01133-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1469-0691.2005.01329.x","volume":"12","author":"G Lorino","year":"2006","unstructured":"Lorino G, Gherardi G, Angeletti S, De Cesaris M, Graziano N, Maringhini S et al (2006) Molecular characterisation and clonal analysis of group A streptococci causing pharyngitis among paediatric patients in Palermo, Italy. Clin Microbiol Infect 12:189\u2013192. doi: 10.1111\/j.1469-0691.2005.01329.x","journal-title":"Clin Microbiol Infect"},{"key":"2414_CR10","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1128\/AAC.46.12.3987-3990.2002","volume":"46","author":"G Dicuonzo","year":"2002","unstructured":"Dicuonzo G, Fiscarelli E, Gherardi G, Lorino G, Battistoni F, Landi S et al (2002) Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 46:3987\u20133990. doi: 10.1128\/AAC.46.12.3987-3990.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s15010-008-8023-1","volume":"37","author":"F Montagnani","year":"2009","unstructured":"Montagnani F, Stolzuoli L, Croci L, Rizzuti C, Arena F, Zanchi A et al (2009) Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region. Infection 37:353\u2013357. doi: 10.1007\/s15010-008-8023-1","journal-title":"Infection"},{"key":"2414_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/10766290252913746","volume":"8","author":"C Zampaloni","year":"2002","unstructured":"Zampaloni C, Vitali LA, Prenna M, Toscano MA, Tempera G, Ripa S (2002) Erythromycin resistance in Italian isolates of Streptococcus pyogenes and correlations with pulsed-field gel electrophoresis analysis. Microb Drug Resist 8:39\u201344","journal-title":"Microb Drug Resist"},{"key":"2414_CR13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/AAC.01484-06","volume":"51","author":"A Brenciani","year":"2007","unstructured":"Brenciani A, Bacciaglia A, Vecchi M, Vitali LA, Varaldo PE, Giovanetti E (2007) Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Antimicrob Agents Chemother 51:1209\u20131216. doi: 10.1128\/AAC.01484-06","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1469-0691.2008.02104.x","volume":"14","author":"C Silva-Costa","year":"2008","unstructured":"Silva-Costa C, Pinto FR, Ramirez M, Melo-Cristino J; Portuguese Surveillance Group for the Study of Respiratory Pathogens (2008) Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin Microbiol Infect 14:1152\u20131159. doi: 10.1111\/j.1469-0691.2008.02104.x","journal-title":"Clin Microbiol Infect"},{"key":"2414_CR15","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH et al (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233\u20132239","journal-title":"J Clin Microbiol"},{"key":"2414_CR16","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.ijid.2011.11.005","volume":"16","author":"A Villase\u00f1or-Sierra","year":"2012","unstructured":"Villase\u00f1or-Sierra A, Katahira E, Jaramillo-Valdivia AN, Barajas-Garc\u00eda M de los A, Bryant A, Morf\u00edn-Otero R et al (2012) Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999\u20132010. Int J Infect Dis 16:e178\u2013e181. doi: 10.1016\/j.ijid.2011.11.005","journal-title":"Int J Infect Dis"},{"key":"2414_CR17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijantimicag.2006.07.005","volume":"28","author":"R Nir-Paz","year":"2006","unstructured":"Nir-Paz R, Block C, Shasha D, Korenman Z, Gorodnitzky Z, Jaffe J et al (2006) Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel. Int J Antimicrob Agents 28:313\u2013319. doi: 10.1016\/j.ijantimicag.2006.07.005","journal-title":"Int J Antimicrob Agents"},{"key":"2414_CR18","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.50.5.1896-1899.2006","volume":"50","author":"P Littauer","year":"2006","unstructured":"Littauer P, Caugant DA, Sangvik M, H\u00f8iby EA, Sundsfjord A, Simonsen GS (2006) Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother 50:1896\u20131899. doi: 10.1128\/AAC.50.5.1896-1899.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR19","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.49.5.2109-2111.2005","volume":"49","author":"C Silva-Costa","year":"2005","unstructured":"Silva-Costa C, Ramirez M, Melo-Cristino J; Portuguese Surveillance Group for the Study of Respiratory Pathogens (2005) Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob Agents Chemother 49:2109\u20132111. doi: 10.1128\/AAC.49.5.2109-2111.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.diagmicrobio.2009.03.004","volume":"64","author":"AG Michos","year":"2009","unstructured":"Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, Roma ES, Pangalis A et al (2009) Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn Microbiol Infect Dis 64:295\u2013299. doi: 10.1016\/j.diagmicrobio.2009.03.004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2414_CR21","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/jac\/dku039","volume":"69","author":"M Montes","year":"2014","unstructured":"Montes M, Tamayo E, Mojica C, Garc\u00eda-Arenzana JM, Esnal O, P\u00e9rez-Trallero E (2014) What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012. J Antimicrob Chemother 69:1474\u20131482. doi: 10.1093\/jac\/dku039","journal-title":"J Antimicrob Chemother"},{"key":"2414_CR22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijmm.2012.09.001","volume":"302","author":"C d\u2019Humi\u00e8res","year":"2012","unstructured":"d\u2019Humi\u00e8res C, Cohen R, Levy C, Bidet P, Thollot F, Wollner A et al (2012) Decline in macrolide-resistant Streptococcus pyogenes isolates from French children. Int J Med Microbiol 302:300\u2013303. doi: 10.1016\/j.ijmm.2012.09.001","journal-title":"Int J Med Microbiol"},{"key":"2414_CR23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10096-011-1362-3","volume":"31","author":"S Farmand","year":"2012","unstructured":"Farmand S, Henneke P, Hufnagel M, Berner R (2012) Significant decline in the erythromycin resistance of group A streptococcus isolates at a German paediatric tertiary care centre. Eur J Clin Microbiol Infect Dis 31:707\u2013710. doi: 10.1007\/s10096-011-1362-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2414_CR24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1128\/AAC.46.6.1816-1822.2002","volume":"46","author":"S Cresti","year":"2002","unstructured":"Cresti S, Lattanzi M, Zanchi A, Montagnani F, Pollini S, Cellesi C et al (2002) Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. Antimicrob Agents Chemother 46:1816\u20131822. doi: 10.1128\/AAC.46.6.1816-1822.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR25","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1809.120049","volume":"18","author":"L Heirstraeten Van","year":"2012","unstructured":"Van Heirstraeten L, Coenen S, Lammens C, Hens N, Goossens H, Malhotra-Kumar S (2012) Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium. Emerg Infect Dis 18:1515\u20131518. doi: 10.3201\/eid1809.120049","journal-title":"Emerg Infect Dis"},{"key":"2414_CR26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/JCM.41.3.1307-1310.2003","volume":"41","author":"C Zampaloni","year":"2003","unstructured":"Zampaloni C, Cappelletti P, Prenna M, Vitali LA, Ripa S (2003) emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J Clin Microbiol 41:1307\u20131310. doi: 10.1128\/JCM.41.3.1307-1310.2003","journal-title":"J Clin Microbiol"},{"key":"2414_CR27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jac\/dkq006","volume":"65","author":"C Ardanuy","year":"2010","unstructured":"Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J et al (2010) Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993\u20132008). J Antimicrob Chemother 65:634\u2013643. doi: 10.1093\/jac\/dkq006","journal-title":"J Antimicrob Chemother"},{"key":"2414_CR28","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/AAC.01318-09","volume":"54","author":"MC Luca Di","year":"2010","unstructured":"Di Luca MC, D\u2019Ercole S, Petrelli D, Prenna M, Ripa S, Vitali LA (2010) Lysogenic transfer of mef(A) and tet(O) genes carried by Phim46.1 among group A streptococci. Antimicrob Agents Chemother 54:4464\u20134466. doi: 10.1128\/AAC.01318-09","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR29","unstructured":"European Centre for Disease Prevention and Control (ECDC). Trend of antimicrobial consumption by country. Available online at: http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/esac-net-database\/Pages\/trend-consumption-by-country.aspx . Accessed 18 March 2015"},{"key":"2414_CR30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2006.07.023","volume":"28","author":"M Cizman","year":"2006","unstructured":"Cizman M, Beovi\u0107 B, Seme K, Paragi M, Strumbelj I, M\u00fcller-Premru M et al (2006) Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use. Int J Antimicrob Agents 28:537\u2013542. doi: 10.1016\/j.ijantimicag.2006.07.023","journal-title":"Int J Antimicrob Agents"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2414-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2414-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2414-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T21:03:48Z","timestamp":1599080628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2414-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,30]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["2414"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2414-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,30]]}}}